Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: May 25, 2010


Amit Meller, an associate professor of biomedical engineering and physics at BU, is a founder of NobleGen Biosciences, a new startup that aims to commercialize nanopore sequencing technology he developed (see article, this issue). His co-founders are Ory Zik, a serial entrepreneur, and Zeev Pearl, an intellectual property lawyer.

Frank Feist is the founding CEO of NobleGen. Most recently, he headed the commercial team of Advalytix, which was acquired by Olympus in 2005 and became part of Beckman Coulter Genomics last year. He holds an MBA from the MIT Sloan School of Management and an MS in electrical and computer engineering from the University of Massachusetts, Amherst.

Phil Buzby recently joined NobleGen as vice president of biochemistry. Until 2008, he was a senior director of intellectual property at Helicos BioSciences, and before that, a senior director of nucleic acid chemistry at Helicos. He holds a PhD in biochemistry from Washington Sate University and a BS in biochemistry and biology from Iowa State University.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.